PH23386A - Macrolide antibiotics,their pharmaceutical composition and method of use thereof - Google Patents

Macrolide antibiotics,their pharmaceutical composition and method of use thereof

Info

Publication number
PH23386A
PH23386A PH33722A PH33722A PH23386A PH 23386 A PH23386 A PH 23386A PH 33722 A PH33722 A PH 33722A PH 33722 A PH33722 A PH 33722A PH 23386 A PH23386 A PH 23386A
Authority
PH
Philippines
Prior art keywords
pharmaceutical composition
macrolide antibiotics
macrolide
antibiotics
pharmaceutical
Prior art date
Application number
PH33722A
Other languages
English (en)
Inventor
John B Ward
Richard A Fletton
Neil Porter
Michael V J Ramsay
Hazel Noble
David Noble
Derek R Sutherland
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858510942A external-priority patent/GB8510942D0/en
Priority claimed from GB858510944A external-priority patent/GB8510944D0/en
Priority claimed from GB858510943A external-priority patent/GB8510943D0/en
Priority claimed from GB868606103A external-priority patent/GB8606103D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of PH23386A publication Critical patent/PH23386A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/22—Cyclohexane rings, substituted by nitrogen atoms
    • C07H15/238—Cyclohexane rings substituted by two guanidine radicals, e.g. streptomycins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/01—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/181—Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Saccharide Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
PH33722A 1985-04-30 1986-04-30 Macrolide antibiotics,their pharmaceutical composition and method of use thereof PH23386A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB858510942A GB8510942D0 (en) 1985-04-30 1985-04-30 Chemical compounds
GB858510944A GB8510944D0 (en) 1985-04-30 1985-04-30 Chemical compounds
GB858510943A GB8510943D0 (en) 1985-04-30 1985-04-30 Chemical compounds
GB868606103A GB8606103D0 (en) 1986-03-12 1986-03-12 Chemical compounds

Publications (1)

Publication Number Publication Date
PH23386A true PH23386A (en) 1989-07-26

Family

ID=27449656

Family Applications (1)

Application Number Title Priority Date Filing Date
PH33722A PH23386A (en) 1985-04-30 1986-04-30 Macrolide antibiotics,their pharmaceutical composition and method of use thereof

Country Status (25)

Country Link
US (1) US4978675A (sv)
JP (1) JPH0819132B2 (sv)
KR (1) KR930011282B1 (sv)
AT (1) AT397095B (sv)
AU (1) AU596586B2 (sv)
BE (1) BE904709A (sv)
CA (1) CA1335368C (sv)
CH (1) CH675124A5 (sv)
DE (1) DE3614549C2 (sv)
DK (1) DK160992C (sv)
ES (4) ES8802229A1 (sv)
FR (1) FR2587344B1 (sv)
GB (1) GB2176182B (sv)
GE (3) GEP19971046B (sv)
HU (1) HU200771B (sv)
IE (1) IE59070B1 (sv)
IL (1) IL78621A (sv)
LU (1) LU86412A1 (sv)
LV (2) LV10777B (sv)
NL (1) NL193420C (sv)
NZ (1) NZ215997A (sv)
PH (1) PH23386A (sv)
PT (1) PT82485B (sv)
RU (1) RU2004545C1 (sv)
SE (1) SE503571C2 (sv)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE502748C2 (sv) * 1984-09-14 1995-12-18 American Cyanamid Co Kemiska föreningar och förfarande för deras framställning
ES8800986A1 (es) * 1985-07-27 1987-12-01 Pfizer Un procedimiento para la produccion de un nuevo derivado de avermectina
EP0215654B1 (en) * 1985-09-13 1995-03-15 American Cyanamid Company Macrolide antibiotics and their preparation
GB8606108D0 (en) * 1986-03-12 1986-04-16 Glaxo Group Ltd Chemical compounds
US5185456A (en) * 1986-03-12 1993-02-09 American Cyanamid Company Macrolide compounds
IE62126B1 (en) * 1986-03-12 1994-12-14 American Cyanamid Co Macrolide compounds
US5336789A (en) * 1986-03-12 1994-08-09 American Cyanamid Company Macrolide compounds
GB8606123D0 (en) * 1986-03-12 1986-04-16 Glaxo Group Ltd Chemical compounds
GB2187742B (en) * 1986-03-12 1990-05-23 Glaxo Group Ltd Macrolide compound
CA1296328C (en) * 1986-03-12 1992-02-25 Derek R. Sutherland Macrolide compounds
CA1296329C (en) * 1986-06-06 1992-02-25 Derek R. Sutherland Macrolide compounds
GB8613790D0 (en) * 1986-06-06 1986-07-09 Glaxo Group Ltd Chemical compounds
US5840704A (en) * 1986-07-16 1998-11-24 Pfizer Inc. Antiparasitic agents and process for their preparation
JP2587241B2 (ja) * 1986-07-24 1997-03-05 ビ−チヤム・グル−プ・ピ−エルシ− 新規化合物、その製法及びそれを含む医薬組成物
EP0260537A1 (en) * 1986-09-12 1988-03-23 American Cyanamid Company 13-Deoxy-23-oxo(keto) and 23-imino derivatives of 13-deoxy C-076-aglycone compounds
DE3782481T2 (de) * 1986-09-12 1993-05-19 American Cyanamid Co 23-deoxy-derivate von ll-f28249-verbindungen.
US4916154A (en) * 1986-09-12 1990-04-10 American Cyanamid Company 23-Imino derivatives of LL-F28249 compounds
US5149832A (en) * 1986-09-12 1992-09-22 American Cyanamid Company Mono and diacyl derivatives of ll-f28249 compounds
ES2058082T3 (es) * 1986-09-12 1994-11-01 American Cyanamid Co Derivados 23-oxo (ceto) y 23-imino de compuestos ll-f28249.
US5234831A (en) * 1987-01-23 1993-08-10 Pfizer Inc Cultures for production of B avermectins
US5525506A (en) * 1987-01-23 1996-06-11 Pfizer Inc. Process for production of avermectins and cultures therefor
US5238848A (en) * 1987-01-23 1993-08-24 Pfizer Inc Cultures for production of avermectins
US4956479A (en) * 1987-03-06 1990-09-11 American Cyanamid Company 23-deoxy-27-chloro derivatives of LL-F28249 compounds
US4886829A (en) * 1987-03-06 1989-12-12 American Cyanamid Company 23-Oxo (keto) and 23-imino derivatives of mono- and diepoxy LL-F28249 compounds
US4886830A (en) * 1987-03-06 1989-12-12 American Cyanamid Company Mono- and diepoxide derivatives of 23-deoxyl-LL-F28249 compounds
US4806527A (en) * 1987-03-16 1989-02-21 Merck & Co., Inc. Avermectin derivatives
US4871719A (en) * 1987-03-24 1989-10-03 Ciba-Geigy Corporation Composition for controlling parasites in productive livestock
EP0285561A3 (de) * 1987-03-27 1989-10-25 Ciba-Geigy Ag Parasitizide und insektizide Milbemycin-Derivate
JPS6431776A (en) * 1987-07-28 1989-02-02 Sankyo Co Novel macrolide compound and production thereof
GB8721377D0 (en) * 1987-09-11 1987-10-21 Glaxo Group Ltd Chemical compounds
HU201327B (en) * 1987-09-11 1990-10-28 American Cyanamid Co Process for production of macrolide compositions
GB8721375D0 (en) * 1987-09-11 1987-10-21 Glaxo Group Ltd Chemical process
GB8721376D0 (en) * 1987-09-11 1987-10-21 Glaxo Group Ltd Chemical compounds
GB8721373D0 (en) * 1987-09-11 1987-10-21 Glaxo Group Ltd Chemical process
GB8721378D0 (en) * 1987-09-11 1987-10-21 Glaxo Group Ltd Chemical process
GB8721647D0 (en) * 1987-09-15 1987-10-21 Pfizer Ltd Antiparasitic agents
US5240850A (en) * 1987-10-23 1993-08-31 Pfizer Inc. Cultures for production of avermectin aglycones
CA1340771C (en) * 1987-11-09 1999-09-28 Shih-Jen Edward Lee Ethylated avermectins
GB8726384D0 (en) * 1987-11-11 1987-12-16 Coopers Animal Health Veterinary treatment
GB8726730D0 (en) 1987-11-14 1987-12-16 Pfizer Ltd Antiparasitic agents
GB8801908D0 (en) * 1988-01-28 1988-02-24 Glaxo Group Ltd Chemical compounds
GB8804440D0 (en) * 1988-02-25 1988-03-23 Pfizer Ltd Antiparasitic agents
HU9203978D0 (en) * 1988-05-10 1993-04-28 American Cyanamid Co Method for producing macrolidic compounds and preparatives containing them qs active substance by means of fermentation
GB8811036D0 (en) * 1988-05-10 1988-06-15 Glaxo Group Ltd Chemical compounds
GB8811037D0 (en) * 1988-05-10 1988-06-15 Glaxo Group Ltd Chemical compounds
GB8813150D0 (en) * 1988-06-03 1988-07-06 American Cyanamid Co Chemical compounds
GB8813760D0 (en) * 1988-06-10 1988-07-13 American Cyanamid Co Chemical process
US5428034A (en) * 1988-09-02 1995-06-27 Sankyo Co., Ltd. Milbemycin derivatives, their preparation and their use
US6001822A (en) * 1989-04-11 1999-12-14 Pfizer Inc. Antiparasitic formulations
EP0393890B1 (en) * 1989-04-11 1992-08-12 Pfizer Limited Injectable compositions containing 25-cyclohexyl-avermectin b1
NZ234802A (en) * 1989-08-14 1992-11-25 Merck & Co Inc Long acting injectable formulations comprising an avermectin compound and triacetin. treatment for internal and external parasites of animals
US4988824A (en) * 1989-09-11 1991-01-29 Maulding Donald R Process for the preparation of 23-(C1-C6 alkyloxime)-LL-F28249 compounds
US5055486A (en) * 1989-12-22 1991-10-08 American Cyanamid Company 13-alkyl-23-imino derivative of LL-F28249 compounds and their use as endo- and ectoparasiticidal, insecticidal, acaricidal and nematocidal agents
JP2622197B2 (ja) * 1990-03-01 1997-06-18 三共株式会社 １３−エーテル置換ミルベマイシン誘導体
US5290804A (en) * 1991-05-01 1994-03-01 Merck & Co., Inc. Anthelmintic milbemycin analogs of novel microorganisms
ATE180671T1 (de) * 1991-09-30 1999-06-15 Merck & Co Inc Hydrierte rizinusöl-enthaltende injizierbare formulierungen mit verlängerter wirkstoffabgabe
US6103504A (en) * 1992-03-25 2000-08-15 Pfizer Inc. Process for production of avermectins and cultures therefor
DE19534366C2 (de) * 1995-09-15 2000-08-17 Asta Medica Ag Verfahren zur Herstellung von 2,3,4,6-Tetra-O-benzyl-D-glucopyranose und 2,3,4,6-Tetra-O-allyl-D-glucopyranose
CA2211949A1 (en) * 1997-07-21 1999-01-29 David Farley Johnson Nonaqueous compositions for parenteral administration
DE60118132T2 (de) 2000-10-10 2006-10-19 Wyeth Anthelmintika
NZ552040A (en) * 2006-12-13 2009-04-30 Bomac Research Ltd Veterinary formulation comprising an anthelmintic compound and glyceryl acetate
WO2012028556A1 (en) 2010-08-31 2012-03-08 Bayer Animal Health Gmbh Macrocyclic lactones and their use and their combinations with other active substances
DE102010064245A1 (de) 2010-12-28 2012-06-28 Bayer Animal Health Gmbh Makrocylischen Lactone und deren Verwendung und deren Kombinationen mit anderen Wirkstoffen

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4201861A (en) * 1977-10-03 1980-05-06 Merck & Co., Inc. Acyl derivatives of C-076 compounds
US4550160A (en) * 1979-08-13 1985-10-29 Merck & Co., Inc. Processes for the interconversion of C-076 compounds
JPS5632481A (en) * 1979-08-23 1981-04-01 Sankyo Co Ltd Antibiotic b-41d, its preparation, and acaricide and anthelminthic agent and repellent containing the same as active constituent
US4289760A (en) * 1980-05-02 1981-09-15 Merck & Co., Inc. 23-Keto derivatives of C-076 compounds
US4457920A (en) * 1981-09-03 1984-07-03 Merck & Co., Inc. 4a-Substituted avermectin compounds
US4423209A (en) * 1982-02-26 1983-12-27 Merck & Co., Inc. Processes for the interconversion of avermectin compounds
JPS59108785A (ja) * 1982-11-25 1984-06-23 Sankyo Co Ltd ミルベマイシン類の５−オキシム誘導体
JPS60126289A (ja) * 1983-11-14 1985-07-05 Sankyo Co Ltd ミルベマイシン類の５−カ−ボネ−ト誘導体
EP0170006B1 (en) * 1984-06-05 1992-07-08 American Cyanamid Company Method and compositions for helmintic, arthropod ectoparasitic and acaridal infections with novel agents
SE502748C2 (sv) * 1984-09-14 1995-12-18 American Cyanamid Co Kemiska föreningar och förfarande för deras framställning
ES8800986A1 (es) * 1985-07-27 1987-12-01 Pfizer Un procedimiento para la produccion de un nuevo derivado de avermectina

Also Published As

Publication number Publication date
NL193420B (nl) 1999-06-01
PT82485B (pt) 1988-03-03
RU2004545C1 (ru) 1993-12-15
GEP19970833B (en) 1997-02-10
GB2176182A (en) 1986-12-17
PT82485A (en) 1986-05-01
ES557517A0 (es) 1988-07-16
ATA115486A (de) 1993-06-15
ES554444A0 (es) 1988-04-16
CA1335368C (en) 1995-04-25
ES557774A0 (es) 1988-12-01
AU5676786A (en) 1986-11-06
GEP20001917B (en) 2000-01-05
SE503571C2 (sv) 1996-07-08
DK196586D0 (da) 1986-04-29
GEP19971046B (en) 1997-11-26
GB8610631D0 (en) 1986-06-04
LV10314B (en) 1995-08-20
FR2587344B1 (fr) 1991-04-05
CH675124A5 (sv) 1990-08-31
NL8601103A (nl) 1986-11-17
JPS61280496A (ja) 1986-12-11
DK160992B (da) 1991-05-13
AU596586B2 (en) 1990-05-10
AT397095B (de) 1994-01-25
GB2176182B (en) 1989-02-01
IE861127L (en) 1986-10-30
DE3614549A1 (de) 1987-01-02
DK160992C (da) 1991-11-11
ES8802522A1 (es) 1988-07-16
JPH0819132B2 (ja) 1996-02-28
HU200771B (en) 1990-08-28
NL193420C (nl) 1999-10-04
ES557851A0 (es) 1990-05-01
HUT46012A (en) 1988-09-28
LU86412A1 (fr) 1986-11-05
BE904709A (fr) 1986-10-30
LV10314A (lv) 1994-10-20
US4978675A (en) 1990-12-18
ES9000023A1 (es) 1990-05-01
FR2587344A1 (fr) 1987-03-20
SE8601998L (sv) 1986-10-31
DE3614549C2 (de) 1998-03-12
ES8802229A1 (es) 1988-04-16
KR930011282B1 (ko) 1993-11-29
SE8601998D0 (sv) 1986-04-29
IE59070B1 (en) 1993-12-15
ES8900093A1 (es) 1988-12-01
LV10777B (en) 1996-04-20
IL78621A0 (en) 1986-08-31
KR860008205A (ko) 1986-11-14
DK196586A (da) 1986-10-31
LV10777A (lv) 1995-08-20
IL78621A (en) 1991-06-30
NZ215997A (en) 1989-06-28

Similar Documents

Publication Publication Date Title
PH23386A (en) Macrolide antibiotics,their pharmaceutical composition and method of use thereof
IL80296A (en) Phenylpyridone derivatives,their preparation and pharmaceutical compositions containing them
IL79323A0 (en) Phenylethanolaminotetralines,their preparation and pharmaceutical compositions containing them
NZ218089A (en) 7-piperazinyl, 4-oxoquinolines and pharmaceutical compositions
PH24719A (en) Cephem compound, pharmaceutical composition containing said compound and method of use thereof
NZ220020A (en) 1-hydroxy-2-pyridones and pharmaceutical composition
PH24180A (en) Macrolide compounds,pharmaceutical composition containing said compound and method of use thereof
IL79402A0 (en) Poly-4-aminopyrrole-2-carboxamido derivatives,their preparation and pharmaceutical compositions containing them
PH24093A (en) Macrolide compounds,pharmaceutical composition containing same and method of use thereof
NZ215947A (en) Vancomycin derivatives and antibiotic composition
IL79039A0 (en) 4-oxoquinolinesulfonamides,their preparation and pharmaceutical compositions containing them
IL79858A0 (en) Peptide antibiotics,their preparation and compositions containing them
AU6791787A (en) Macrolide antibiotics and their preparation
AR242193A1 (es) Procedimiento para la preparacion de 4-/4,5-dihidro-2-imidazolil(o 2-oxazolil o 2-tiazolil)7-amino-5(o 3,5)-halogeno benzamida e intermediarios de sintesis utilizados segun dicho procedimiento.
NZ217248A (en) Gem-dihalo-1,8-diamino-4-aza-octones and pharmaceutical compositions
PH22247A (en) Diazepinoindole, pharmaceutical composition and method of use thereof
ZA864886B (en) Antibiotic method and formulations
DE3665720D1 (en) Novel ll-methylene-oestr-15-enes, processes for their preparation, and pharmaceutical compositions
IL77614A0 (en) Interfuranylene-prostacyclin derivatives,their preparation and pharmaceutical compositions containing them
PH22258A (en) Peptide immunostimulant, pharmaceutical composition containing the same and method of use thereof
PH24246A (en) New 1-aryloxy-dihydrobenzothiadiazinylalkylamino-alkanes,pharmaceutical compositions containing same and method of use thereof
IL78534A0 (en) Eburnamenine derivatives,their preparation and pharmaceutical compositions containing them
PH25227A (en) Aromatic w-alkylamino-tetrahydro-6h-1,3-thiazin-6-one derivatives, pharmaceutical composition containing same and method of use thereof
ZA863243B (en) Macrolide antibiotics and their preparation
ZA866959B (en) Macrolide antibiotics and their preparation